CTRI/2015/02/005534
Completed
未知
Clinical Study to Evaluate Safety and Efficacy of Romantaque Lotion in Healthy Human Volunteers according to IS 4011:1997/2009 Guidelines.
Mrs Mrinmayee Bhushan Kondhalkar0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mrs Mrinmayee Bhushan Kondhalkar
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subject did not have any known illness, infection
- •2\.Subject did not have any Known allergy/ sensitivity
- •3\.Clinically Healthy subject
Exclusion Criteria
- •1\. Patients Having Known Skin diseases
- •2\.Patients of age below 18 years and above 60 years were excluded from study.
- •3\.Pregnant women and planning to be pregnant within six months were excluded from study.
- •4\.Lactating Mother
- •5\.Malignant and accelerated hypertensive
- •6\.Patient undergoing regular treatment for Diabetes or for any other severe illness
- •7\.Patients who had not signed Informed Consent form.
- •8\.Any condition that, in the opinion of the investigator, did not justify the patientsâ?? inclusion for the study.
- •9\.Gender Male
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Effect of Boozidaan(Pyrethrum Indicum)on Niqris Muzmin(chronic gout)Health Condition 1: M1A9- Chronic gout, unspecifiedCTRI/2021/03/032150Central council for Research in Unani Medicine New Delhi
Unknown
Phase 3
A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood PressureHypertensionJPRN-jRCT2080220304ovartis Pharma K.K.356
Recruiting
Phase 2
Clinical Study on Diabetes supplement in participants with diabetes.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2024/04/065001Emil Pharmaceutical Industries Private Limited,
Completed
Phase 2
A clinical of Appetol syrup in children suffering from non-specific anorexia (loss of appetite)CTRI/2014/07/004756ARJUN HEALTHCARE50
Recruiting
Phase 3
Clinical trial of Lipidil Tablet in comparison with Atorvastatin in patients with abnormal amount of lipids.Health Condition 1: null- DyslipidemiaCTRI/2014/09/005015Arjun Healthcare80